Workarounds to U.S. regulation
24:00–25:31 · 91s
Shah argues patients will increasingly leave the U.S. for innovative therapies due to FDA and pharma roadblocks, predicting a global shift in where breakthroughs happen.
24:00–25:31 · 91s
Shah argues patients will increasingly leave the U.S. for innovative therapies due to FDA and pharma roadblocks, predicting a global shift in where breakthroughs happen.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.